- Leads the creation of the strategic global medical plan for Pharma Therapeutic Area
product, in alignment with the countries’ medical planning and in alignment with the global
business function and other internal stakeholders
- Executes some strategically important parts of the global medical plans, like KOL
relationship management activities
- Oversees and monitors the execution of the global medical plans
- Contributes to / provide the medical strategy for global Phase IV medical affairs studies to
support the commercial success of Bayer Pharma Therapeutic Area products
- Plans and coordinates the design, conduct, analysis, reporting and publication of Phase IV
Studies - Contributes to / Provides the strategic review of Bayer Pharma Therapeutic Area
ISS and NIS studies
- Provides medical affairs input to global clinical development programs
- Ensures all regional studies are consistent with agreed medical strategy
- Oversees and monitors the long-term communication plans in Bayer Pharma Therapeutic
Area; this includes the long term medical affairs study and data generation plans
- Interprets information from Bayer’s clinical development studies, medical affairs studies,
and from external sources, to generate communication materials and documents for
internal and external use, including slide decks, training material, Q&As and others
- Leads the Global Content Network for medical information document generation in the
Bayer Pharma Therapeutic Area field. Updates, organizes and maintains the global medical
information documents within the SHERLOCK repository
- Provide Medical review of promotional material from the GBT for global use e.g. product
monographs, brochures, press releases, Q&As, field communications
- Contributes to the Bayer Pharma Therapeutic Area Global Brand Team’s work by providing
medical expertise and insight on commercial issues
- Provides the global medical affairs contributions to the global brand plans in Bayer Pharma
Therapeutic Area
- Provides Medical Affairs input to core labeling and pharmacovigilance documents for
marketed products
- Ensures excellence in medical governance activities for Bayer Pharma Therapeutic Area,
including the collaboration with co-development partner companies
- Establishes professional relationships with global clinical investigators, opinion leaders, and
consultants in the medical community
- Represents Bayer Pharma viewpoint on products to key opinion leaders, scientific advisors,
health authorities and to other external stakeholders
- Plans and monitors the global medical affairs budget for Bayer Pharma Therapeutic Area,
in collaboration with the global business function and our external co-development partners
- Maintains and develops relationships with scientific communications agencies, clinical
research organizations, and other service providers as required to support excellence in
global launch and post-launch medical affairs operations